{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T15:07:34Z","timestamp":1775488054743,"version":"3.50.1"},"reference-count":62,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2020,4,29]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Treatment of neurological diseases using systemic and non-surgical techniques\npresents a significant challenge in medicine. This challenge is chiefly associated with the condensation\nand coherence of the brain tissue.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The coherence structure of the brain is due to the presence of the blood-brain barrier (BBB),\nwhich consists of a continuous layer of capillary endothelial cells. The BBB prevents most drugs from\nentering the brain tissue and is highly selective, permitting only metabolic substances and nutrients to\npass through.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Although this challenge has caused difficulties for the treatment of neurological diseases, it\nhas opened up a broad research area in the field of drug delivery. Through the utilization of nanoparticles\n(NPs), nanotechnology can provide the ideal condition for passing through the BBB.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>NPs with suitable dimensions and optimum hydrophobicity and charge, as well as appropriate\nfunctionalization, can accumulate in the brain. Furthermore, NPs can facilitate the targeted delivery\nof therapeutics into the brain areas involved in Alzheimer\u2019s disease, Parkinson\u2019s disease, stroke,\nglioma, migraine, and other neurological disorders. This review describes these methods of actively\ntargeting specific areas of the brain.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389201020666191203094057","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T13:38:22Z","timestamp":1575380302000},"page":"374-383","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Active Targeting Towards and Inside the Brain based on Nanoparticles: A Review"],"prefix":"10.2174","volume":"21","author":[{"given":"Morteza","family":"Rabiei","sequence":"first","affiliation":[{"name":"Department of Nanobiotechnology, Razi University, Kermanshah, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8836-3647","authenticated-orcid":true,"given":"Soheila","family":"Kashanian","sequence":"additional","affiliation":[{"name":"Department of Nanobiotechnology, Razi University, Kermanshah, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0297-6811","authenticated-orcid":true,"given":"Seyedeh S.","family":"Samavati","sequence":"additional","affiliation":[{"name":"Department of Nanobiotechnology, Razi University, Kermanshah, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6384-6818","authenticated-orcid":true,"given":"Shahriar","family":"Jamasb","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Hamedan University of Technology, Hamedan, 65169-13733, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4415-619X","authenticated-orcid":true,"given":"Steven J.P.","family":"McInnes","sequence":"additional","affiliation":[{"name":"University of South Australia, Division of Information Technology, Engineering and the Environment, Mawson Lakes, Mawson Lakes 5095, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/10717544.2018.1428243","volume":"25","author":"Karthivashan G.","year":"2018","unstructured":"Karthivashan G.; Ganesan P.; Park S-Y.; Kim J-S.; Choi D-K.; Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer\u2019s disease. Drug Deliv 2018,25(1),307-320","journal-title":"Drug Deliv"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuron.2013.12.023","volume":"81","author":"Bell R.D.","year":"2014","unstructured":"Bell R.D.; Ehlers M.D.; Breaching the blood-brain barrier for drug delivery. Neuron 2014,81(1),1-3","journal-title":"Neuron"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1517\/17425247.2016.1162152","volume":"13","author":"Choonara Y.E.","year":"2016","unstructured":"Choonara Y.E.; Kumar P.; Modi G.; Pillay V.; Improving drug delivery technology for treating neurodegenerative diseases. Expert Opin Drug Deliv 2016,13(7),1029-1043","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2013.08.008","volume":"71","author":"Kreuter J.","year":"2014","unstructured":"Kreuter J.; Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev 2014,71,2-14","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.2147\/IJN.S165210","volume":"13","author":"Muhamad N.","year":"2018","unstructured":"Muhamad N.; Plengsuriyakarn T.; Na-Bangchang K.; Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional\/herbal medicines in cancer therapy: a systematic review. Int J Nanomedicine 2018,13,3921-3935","journal-title":"Int J Nanomedicine"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.7150\/thno.21254","volume":"8","author":"Dong X.","year":"2018","unstructured":"Dong X.; Current strategies for brain drug delivery. Theranostics 2018,8(6),1481-1493","journal-title":"Theranostics"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.apsb.2016.05.013","volume":"6","author":"Gao H.","year":"2016","unstructured":"Gao H.; Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharm Sin B 2016,6(4),268-286","journal-title":"Acta Pharm Sin B"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","volume":"235","author":"Saraiva C.","year":"2016","unstructured":"Saraiva C.; Pra\u00e7a C.; Ferreira R.; Santos T.; Ferreira L.; Bernardino L.; Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. J Control Release 2016,235,34-47","journal-title":"J Control Release"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrd.2015.21","volume":"15","author":"Banks W.A.","year":"2016","unstructured":"Banks W.A.; From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discov 2016,15(4),275-292","journal-title":"Nat Rev Drug Discov"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2016.04.008","volume":"142","author":"Das S.","year":"2016","unstructured":"Das S.; Carnicer-Lombarte A.; Fawcett J.W.; Bora U.; Bio-inspired nano tools for neuroscience. Prog Neurobiol 2016,142,1-22","journal-title":"Prog Neurobiol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.schres.2016.11.027","volume":"184","author":"Katare Y.K.","year":"2017","unstructured":"Katare Y.K.; Piazza J.E.; Bhandari J.; Daya R.P.; Akilan K.; Simpson M.J.; Hoare T.; Mishra R.K.; Intranasal delivery of antipsychotic drugs. Schizophr Res 2017,184,2-13","journal-title":"Schizophr Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","volume":"64","author":"Chen Y.","year":"2012","unstructured":"Chen Y.; Liu L.; Modern methods for delivery of drugs across the blood-brain barrier. Adv Drug Deliv Rev 2012,64(7),640-665","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3390\/pharmaceutics11050245","volume":"11","author":"Parodi A.","year":"2019","unstructured":"Parodi A.; Rudzi\u0144ska M.; Deviatkin A.A.; Soond S.M.; Baldin A.V.; Zamyatnin A.A.; Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer. Pharmaceutics 2019,11(5),245","journal-title":"Pharmaceutics"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40263-016-0405-9","volume":"31","author":"Patel M.M.","year":"2017","unstructured":"Patel M.M.; Patel B.M.; Crossing the blood\u2013brain barrier: recent advances in drug delivery to the brain. CNS Drugs 2017,31(2),109-133","journal-title":"CNS Drugs"},{"key":"ref=15","author":"Sharma K.","year":"2017","unstructured":"Sharma K.; Harikumar S.;  Recent Advancement in drug delivery system for brain: An Overview2017"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1039\/C4CC09871D","volume":"51","author":"Garg P.","year":"2015","unstructured":"Garg P.; Pandey S.; Seonwoo H.; Yeom S.; Choung Y-H.; Cho C-S.; Choung P-H.; Hoon Chung J.; Hyperosmotic polydixylitol for crossing the blood brain barrier and efficient nucleic acid delivery. Chem Commun (Camb) 2015,51(17),3645-3648","journal-title":"Chem Commun (Camb)"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jconrel.2015.08.059","volume":"219","author":"Timbie K.F.","year":"2015","unstructured":"Timbie K.F.; Mead B.P.; Price R.J.; Drug and gene delivery across the blood-brain barrier with focused ultrasound. J Control Release 2015,219,61-75","journal-title":"J Control Release"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jddst.2016.05.003","volume":"35","author":"Warnken Z.N.","year":"2016","unstructured":"Warnken Z.N.; Smyth H.D.; Watts A.B.; Weitman S.; Kuhn J.G.; Williams R.O.; Formulation and device design to increase nose to brain drug delivery. J Drug Deliv Sci Technol 2016,35,213-222","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12668-016-0212-2","volume":"6","author":"Borodina T.","year":"2016","unstructured":"Borodina T.; Trushina D.; Marchenko I.; Bukreeva T.; Calcium carbonate-based mucoadhesive microcontainers for intranasal delivery of drugs bypassing the blood\u2013brain barrier. Bionanoscience 2016,6(3),261-268","journal-title":"Bionanoscience"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11481-016-9690-9","volume":"12","author":"Hirschberg H.","year":"2017","unstructured":"Hirschberg H.; Madsen S.J.; Cell mediated photothermal therapy of brain tumors. J Neuroimmune Pharmacol 2017,12(1),99-106","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3390\/pharmaceutics6040557","volume":"6","author":"Georgieva J.V.","year":"2014","unstructured":"Georgieva J.V.; Hoekstra D.; Zuhorn I.S.; Smuggling drugs into the brain: an overview of ligands targeting transcytosis for drug delivery across the blood\u2013brain barrier. Pharmaceutics 2014,6(4),557-583","journal-title":"Pharmaceutics"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1007\/s12035-015-9672-6","volume":"54","author":"Patching S.G.","year":"2017","unstructured":"Patching S.G.; Glucose transporters at the blood-brain barrier: function, regulation and gateways for drug delivery. Mol Neurobiol 2017,54(2),1046-1077","journal-title":"Mol Neurobiol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ijpharm.2016.09.042","volume":"513","author":"Lungare S.","year":"2016","unstructured":"Lungare S.; Hallam K.; Badhan R.K.; Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery. Int J Pharm 2016,513(1-2),280-293","journal-title":"Int J Pharm"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jddst.2016.06.012","volume":"37","author":"Ghasemian E.","year":"2017","unstructured":"Ghasemian E.; Vatanara A.; Navidi N.; Rouini M.R.; Brain delivery of baclofen as a hydrophilic drug by nanolipid carriers: Characteristics and pharmacokinetics evaluation. J Drug Deliv Sci Technol 2017,37,67-73","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.phrs.2015.12.024","volume":"104","author":"Wang J-Z.","year":"2016","unstructured":"Wang J-Z.; Xiao N.; Zhang Y-Z.; Zhao C-X.; Guo X-H.; Lu L-M.; Mfsd2a-based pharmacological strategies for drug delivery across the blood-brain barrier. Pharmacol Res 2016,104,124-131","journal-title":"Pharmacol Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.apsb.2018.01.004","volume":"8","author":"Dai T.","year":"2018","unstructured":"Dai T.; Jiang K.; Lu W.; Liposomes and lipid disks traverse the BBB and BBTB as intact forms as revealed by two-step F\u00f6rster resonance energy transfer imaging. Acta Pharm Sin B 2018,8(2),261-271","journal-title":"Acta Pharm Sin B"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijpharm.2016.09.054","volume":"515","author":"Nakao Y.","year":"2016","unstructured":"Nakao Y.; Horiguchi M.; Nakamura R.; Sasaki-Hamada S.; Ozawa C.; Funane T.; Ozawa R.; Oka J-I.; Yamashita C.; LARETH-25 and \u03b2-CD improve central transitivity and central pharmacological effect of the GLP-2 peptide. Int J Pharm 2016,515(1-2),37-45","journal-title":"Int J Pharm"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12951-016-0177-x","volume":"14","author":"Neves A.R.","year":"2016","unstructured":"Neves A.R.; Queiroz J.F.; Reis S.; Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E. J Nanobiotechnology 2016,14(1),27","journal-title":"J Nanobiotechnology"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11481-016-9685-6","volume":"12","author":"Gomes M.J.","year":"2017","unstructured":"Gomes M.J.; Fernandes C.; Martins S.; Borges F.; Sarmento B.; Tailoring lipid and polymeric nanoparticles as siRNA carriers towards the blood-brain barrier\u2013from targeting to safe administration. J Neuroimmune Pharmacol 2017,12(1),107-119","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref=30","volume":"30","author":"M\u00e4ger I.","year":"2016","unstructured":"M\u00e4ger I.; Meyer A. H.; Li J.; Lenter M.; Hildebrandt T.; Leparc G.; Wood M.;  Neuropharmacology 2016,30","journal-title":"Neuropharmacology"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"11980","DOI":"10.1038\/ncomms11980","volume":"7","author":"Mann A.P.","year":"2016","unstructured":"Mann A.P.; Scodeller P.; Hussain S.; Joo J.; Kwon E.; Braun G.B.; M\u00f6lder T.; She Z-G.; Kotamraju V.R.; Ranscht B.; Krajewski S.; Teesalu T.; Bhatia S.; Sailor M.J.; Ruoslahti E.; A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries. Nat Commun 2016,7,11980","journal-title":"Nat Commun"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.biomaterials.2013.09.063","volume":"35","author":"Zhang C.","year":"2014","unstructured":"Zhang C.; Wan X.; Zheng X.; Shao X.; Liu Q.; Zhang Q.; Qian Y.; Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer\u2019s disease mice. Biomaterials 2014,35(1),456-465","journal-title":"Biomaterials"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.eurpolymj.2017.11.038","volume":"98","author":"Li H.Y.","year":"2018","unstructured":"Li H.Y.; Zhang B.; Chan P.S.; Weng J.; Tsang C.K.; Lee W.Y.T.; Convergent synthesis and characterization of fatty acid-conjugated poly (ethylene glycol)-block-poly (epsilon-caprolactone) nanoparticles for improved drug delivery to the brain. Eur Polym J 2018,98,394-401","journal-title":"Eur Polym J"},{"key":"ref=34","doi-asserted-by":"publisher","DOI":"10.1142\/S179329201850008X","volume":"13","author":"Wang L.","year":"2018","unstructured":"Wang L.; Zhao Y.; Lu R.; Peng Y.; Guo L.; Hai L.; Guan M.; Wu Y.; Preparation and Characterization of Novel Brain Targeting Magnetic Nanoparticles Modified with Ascorbic Acid. Nano 2018,13(01)","journal-title":"Nano"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/21691401.2018.1451873","volume":"46","author":"Alam M.","year":"2018","unstructured":"Alam M.; Najmi A.K.; Ahmad I.; Ahmad F.J.; Akhtar M.J.; Imam S.S.; Akhtar M.;  Artif Cells Nanomed\nBiotechnol 2018,46(sup2),46-57","journal-title":"Artif Cells Nanomed\nBiotechnol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1038\/s41467-019-11593-z","volume":"10","author":"Zhang Z.","year":"2019","unstructured":"Zhang Z.; Guan J.; Jiang Z.; Yang Y.; Liu J.; Hua W.; Mao Y.; Li C.; Lu W.; Qian J.; Zhan C.; Brain-targeted drug delivery by manipulating protein corona functions. Nat Commun 2019,10(1),3561","journal-title":"Nat Commun"},{"key":"ref=37","author":"Blanco-Prieto M. J.","year":"2015","unstructured":"Blanco-Prieto M. J.; Luquin M. R.; Carmona-Abellan M.; Garbayo E.; Rodriguez-Nogales C.;  Brain aging and Parkinson's disease: new therapeutic approaches using drugs delivery systems 2015","journal-title":"Brain aging and Parkinson's disease: new therapeutic approaches using drugs delivery systems"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11095-015-1774-3","volume":"33","author":"Lindqvist A.","year":"2016","unstructured":"Lindqvist A.; Rip J.; van Kregten J.; Gaillard P.J.; Hammarlund-Udenaes M.; \n                        In vivo functional evaluation of increased brain delivery of the opioid peptide DAMGO by Glutathione-PEGylated liposomes. Pharm Res 2016,33(1),177-185","journal-title":"Pharm Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1021\/acsami.8b18664","volume":"11","author":"Fu S.","year":"2019","unstructured":"Fu S.; Liang M.; Wang Y.; Cui L.; Gao C.; Chu X.; Liu Q.; Feng Y.; Gong W.; Yang M.; Li Z.; Yang C.; Xie X.; Yang Y.; Gao C.; Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma. ACS Appl Mater Interfaces 2019,11(2),1841-1854","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1007\/s11095-016-1910-8","volume":"33","author":"Girotra P.","year":"2016","unstructured":"Girotra P.; Singh S.K.; A comparative study of orally delivered PBCA and ApoE coupled BSA nanoparticles for brain targeting of sumatriptan succinate in therapeutic management of migraine. Pharm Res 2016,33(7),1682-1695","journal-title":"Pharm Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.addr.2016.02.008","volume":"103","author":"Nair M.","year":"2016","unstructured":"Nair M.; Jayant R.D.; Kaushik A.; Sagar V.; Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS. Adv Drug Deliv Rev 2016,103,202-217","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/1061186X.2017.1365874","volume":"26","author":"Zamanlu M.","year":"2018","unstructured":"Zamanlu M.; Farhoudi M.; Eskandani M.; Mahmoudi J.; Barar J.; Rafi M.; Omidi Y.; Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke. J Drug Target 2018,26(2),95-109","journal-title":"J Drug Target"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/nnano.2014.274","volume":"9","author":"Gaudin A.","year":"2014","unstructured":"Gaudin A.; Yemisci M.; Eroglu H.; Lepetre-Mouelhi S.; Turkoglu O.F.; D\u00f6nmez-Demir B.; Caban S.; Sargon M.F.; Garcia-Argote S.; Pieters G.; Loreau O.; Rousseau B.; Tagit O.; Hildebrandt N.; Le Dantec Y.; Mougin J.; Valetti S.; Chacun H.; Nicolas V.; Desma\u00eble D.; Andrieux K.; Capan Y.; Dalkara T.; Couvreur P.; Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury. Nat Nanotechnol 2014,9(12),1054-1062","journal-title":"Nat Nanotechnol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.phymed.2010.03.017","volume":"17","author":"Tang C.","year":"2010","unstructured":"Tang C.; Xue H.; Bai C.; Fu R.; Wu A.; The effects of Tanshinone IIA on blood-brain barrier and brain edema after transient middle cerebral artery occlusion in rats. Phytomedicine 2010,17(14),1145-1149","journal-title":"Phytomedicine"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1080\/10611860903112842","volume":"17","author":"Kurakhmaeva K.B.","year":"2009","unstructured":"Kurakhmaeva K.B.; Djindjikhashvili I.A.; Petrov V.E.; Balabanyan V.U.; Voronina T.A.; Trofimov S.S.; Kreuter J.; Gelperina S.; Begley D.; Alyautdin R.N.; Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles. J Drug Target 2009,17(8),564-574","journal-title":"J Drug Target"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1021\/bc400055h","volume":"24","author":"Liu Z.","year":"2013","unstructured":"Liu Z.; Gao X.; Kang T.; Jiang M.; Miao D.; Gu G.; Hu Q.; Song Q.; Yao L.; Tu Y.; Chen H.; Jiang X.; Chen J.; B6 peptide-modified PEG-PLA nanoparticles for enhanced brain delivery of neuroprotective peptide. Bioconjug Chem 2013,24(6),997-1007","journal-title":"Bioconjug Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.biomaterials.2009.09.104","volume":"31","author":"Wang Z.H.","year":"2010","unstructured":"Wang Z.H.; Wang Z.Y.; Sun C.S.; Wang C.Y.; Jiang T.Y.; Wang S.L.; Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain. Biomaterials 2010,31(5),908-915","journal-title":"Biomaterials"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00702-016-1527-4","volume":"124","author":"Baysal I.","year":"2017","unstructured":"Baysal I.; Ucar G.; Gultekinoglu M.; Ulubayram K.; Yabanoglu-Ciftci S.; Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro. J Neural Transm (Vienna) 2017,124(1),33-45","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032616","volume":"7","author":"Mathew A.","year":"2012","unstructured":"Mathew A.; Fukuda T.; Nagaoka Y.; Hasumura T.; Morimoto H.; Yoshida Y.; Maekawa T.; Venugopal K.; Kumar D.S.; Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer\u2019s disease. PLoS One 2012,7(3)","journal-title":"PLoS One"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"8749","DOI":"10.2147\/IJN.S144545","volume":"12","author":"Bhatt P.C.","year":"2017","unstructured":"Bhatt P.C.; Verma A.; Al-Abbasi F.A.; Anwar F.; Kumar V.; Panda B.P.; Development of surface-engineered PLGA nanoparticulate-delivery system of Tet1-conjugated nattokinase enzyme for inhibition of A\u03b2 plaques in Alzheimer\u2019s disease. Int J Nanomedicine 2017,12,8749-8768","journal-title":"Int J Nanomedicine"},{"key":"ref=51","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201703982","volume":"28","author":"Jiang Y.","year":"2018","unstructured":"Jiang Y.; Fay J.M.; Poon C.D.; Vinod N.; Zhao Y.; Bullock K.; Qin S.; Manickam D.S.; Yi X.; Banks W.A.; Kabanov A.V.; Nanoformulation of Brain-Derived Neurotrophic Factor with Target Receptor-Triggered-Release in the Central Nervous System. Adv Funct Mater 2018,28(6)","journal-title":"Adv Funct Mater"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1021\/nn506408v","volume":"9","author":"Pahuja R.","year":"2015","unstructured":"Pahuja R.; Seth K.; Shukla A.; Shukla R.K.; Bhatnagar P.; Chauhan L.K.S.; Saxena P.N.; Arun J.; Chaudhari B.P.; Patel D.K.; Singh S.P.; Shukla R.; Khanna V.K.; Kumar P.; Chaturvedi R.K.; Gupta K.C.; Trans-blood brain barrier delivery of dopamine-loaded nanoparticles reverses functional deficits in parkinsonian rats. ACS Nano 2015,9(5),4850-4871","journal-title":"ACS Nano"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/jgm.1361","volume":"11","author":"Huang R.","year":"2009","unstructured":"Huang R.; Han L.; Li J.; Ren F.; Ke W.; Jiang C.; Pei Y.; Neuroprotection in a 6-hydroxydopamine-lesioned Parkinson model using lactoferrin-modified nanoparticles. J Gene Med: A Cross-\nDiscipl J Res Sci Gene Transfer Clin Appl 2009,11(9),754-763","journal-title":"J Gene Med: A Cross-\nDiscipl J Res Sci Gene Transfer Clin Appl"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1021\/jp501114h","volume":"118","author":"Yang J.A.","year":"2014","unstructured":"Yang J.A.; Lin W.; Woods W.S.; George J.M.; Murphy C.J.; \u03b1-Synuclein\u2019s adsorption, conformation, and orientation on cationic gold nanoparticle surfaces seeds global conformation change. J Phys Chem B 2014,118(13),3559-3571","journal-title":"J Phys Chem B"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s10103-016-1955-2","volume":"31","author":"Dong H.","year":"2016","unstructured":"Dong H.; Jin M.; Liu Z.; Xiong H.; Qiu X.; Zhang W.; Guo Z.; \n                        In vitro and in vivo brain-targeting chemo-photothermal therapy using graphene oxide conjugated with transferrin for Gliomas. Lasers Med Sci 2016,31(6),1123-1131","journal-title":"Lasers Med Sci"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ijpharm.2016.01.018","volume":"500","author":"Garanti T.","year":"2016","unstructured":"Garanti T.; Stasik A.; Burrow A.J.; Alhnan M.A.; Wan K-W.; Anti-glioma activity and the mechanism of cellular uptake of asiatic acid-loaded solid lipid nanoparticles. Int J Pharm 2016,500(1-2),305-315","journal-title":"Int J Pharm"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ijpharm.2016.02.038","volume":"503","author":"El-Zaafarany G.M.","year":"2016","unstructured":"El-Zaafarany G.M.; Soliman M.E.; Mansour S.; Awad G.A.; Identifying lipidic emulsomes for improved oxcarbazepine brain targeting: In vitro and rat in vivo studies. Int J Pharm 2016,503(1-2),127-140","journal-title":"Int J Pharm"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1208\/s12249-016-0532-0","volume":"18","author":"Girotra P.","year":"2017","unstructured":"Girotra P.; Singh S.K.; Multivariate optimization of rizatriptan benzoate-loaded solid lipid nanoparticles for brain targeting and migraine management. AAPS PharmSciTech 2017,18(2),517-528","journal-title":"AAPS PharmSciTech"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neuro.2015.12.020","volume":"53","author":"Krishnan J.K.S.","year":"2016","unstructured":"Krishnan J.K.S.; Arun P.; Appu A.P.; Vijayakumar N.; Figueiredo T.H.; Braga M.F.M.; Baskota S.; Olsen C.H.; Farkas N.; Dagata J.; Frey W.H.; Moffett J.R.; Namboodiri A.M.A.; Intranasal delivery of obidoxime to the brain prevents mortality and CNS damage from organophosphate poisoning. Neurotoxicology 2016,53,64-73","journal-title":"Neurotoxicology"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"12991","DOI":"10.1038\/s41598-018-31285-w","volume":"8","author":"Jayant R.D.","year":"2018","unstructured":"Jayant R.D.; Tiwari S.; Atluri V.; Kaushik A.; Tomitaka A.; Yndart A.; Colon-Perez L.; Febo M.; Nair M.; Multifunctional Nanotherapeutics for the Treatment of neuroAIDS in Drug Abusers. Sci Rep 2018,8(1),12991","journal-title":"Sci Rep"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.nano.2015.06.006","volume":"11","author":"Ma J.","year":"2015","unstructured":"Ma J.; Porter A.L.; Aminabhavi T.M.; Zhu D.; Nano-enabled drug delivery systems for brain cancer and Alzheimer\u2019s disease: research patterns and opportunities. Nanomedicine (Lond) 2015,11(7),1763-1771","journal-title":"Nanomedicine (Lond)"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1140\/epjst\/e2015-50266-2","volume":"225","author":"Tavares M.","year":"2016","unstructured":"Tavares M.; De Menezes L.; Do Nascimento D.; Souza D.; Reynaud F.; Marques M.; Tavares M.; Polymeric nanoparticles assembled with microfluidics for drug delivery across the blood-brain barrier. Eur Phys J Spec Top 2016,225(4),779-795","journal-title":"Eur Phys J Spec Top"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/177113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T17:48:54Z","timestamp":1592243334000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/177113\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,29]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,4,29]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389201020666191203094057","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,29]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-07-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}